Navigation Links
ViroPharma to Participate In Three May Healthcare Investor Conferences
Date:4/27/2011

EXTON, Pa., April 27, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Deutsche Bank 36th Annual Healthcare Conference at 10:40 A.M. ET on Tuesday, May 3, 2011.  The conference is being held at the InterContinental Hotel in Boston, MA.

Vincent Milano, president and chief executive officer of ViroPharma, will present at the Bank of America/Merrill Lynch 2011 Healthcare Conference at 3:40 P.M. PT (6:40 P.M. ET) on Wednesday, May 11, 2011.  The conference is being held at the Wynn Hotel in Las Vegas, NV.

William Roberts, vice president, corporate communications of ViroPharma will present at the ThinkEquity 2nd Annual Healthcare Conference at 11:30 A.M. ET on Wednesday, May 25, 2011. The conference is being held at the Princeton Club in New York City.

ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze™ (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, incl
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Vermillion, Inc. (Nasdaq: ... focused on gynecologic disease, announced today it will ... the market open on Wednesday, March 25, 2015, ... at 8:30am Eastern. Conference Call & Webcast: ... Eastern/5:30am Pacific Domestic: , 800-753-9057International: , 913-981-5571Conference ID: ...
(Date:3/5/2015)... 5, 2015  BioPhotas, Inc., an FDA registered medical ... photo-therapeutic technologies to treat skin, muscle and joint conditions, ... Fi Fund to provide BioPhotas, flagship product, the ... management solutions.  Commenting on the alliance, ... used the Celluma at the Warrior Hope and Care ...
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... 2011 As the biopharmaceutical marketplace has evolved, leading ... to change as well. Specifically, Market Research is shifting ... shaping strategic objectives for key commercial groups. ... increasingly use new and innovative tools such as Webcams ...
... 10, 2011 American Medical Systems® (AMS) (Nasdaq: ... and therapies for male and female pelvic health, today ... of the Elevate® Anterior and Apical Prolapse Repair System. ... quantify, describe and stage pelvic support, was implemented in ...
Cached Medicine Technology:Strategic Role Becoming Critical Part of Market Research Function 2Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2
(Date:3/5/2015)... Battle Creek, Michigan (PRWEB) March 05, 2015 ... celebrates the opportunity to shatter myths about drug and ... Forever Recovery has released a Fact Sheet with information ... substance abuse. Launched in 2010 by the National Institute ... about drugs and alcohol aims to counteract the illusions ...
(Date:3/5/2015)... Anaheim, Calif. (PRWEB) March 05, 2015 ... plant-powered beverages, today announced at Natural Products Expo West ... drinks are now 100 percent soy and dairy free. ... 10.5-ounce single serve bottle and are packed with six ... rice protein that includes fiber, B vitamins and magnesium. ...
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has officially ... in the supply chain industry, and we are excited ... were included on this year’s list! Russ King and ... to their hard work, their commitment to excellence, and ... client needs and challenges. , Russ and ...
(Date:3/5/2015)... March 05, 2015 As a ... (AAPA) review of Clearstream, LLC ’s products, ... Clearstream’s MediDefense line of products—led by their mPulse ... Affinity Partner Program. , The AAPA—which represents a ... all medical and surgical specialties in the U.S.—advocates ...
(Date:3/5/2015)... Park, California (PRWEB) March 05, 2015 ... (JCAP) last week released a special issue ... in the field of PANDAS (Pediatric Autoimmune Neuropsychiatric ... Neuropsychiatric Syndromes), an autoimmune reaction triggered by infections ... lyme, which result in inflammation of the child's ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3
... University of Jerusalem faculty members have been named winners ... research efforts which have yielded highly successful business applications ... Robert H. Smith Faculty of Agriculture, Food and Environment ... winner of the first prize. Rabinowitch, a former rector ...
... 22 June 2011 Elsevier Middle East announces that ... selected for inclusion in MEDLINE, the premier bibliographic database ... for articles indexed, the indexing terms and the abstract ... ( www.pubmed.gov ). Indexing using the US National Library ...
... lateral sclerosis (ALS) could lose brain function earlier than ... about their care. Physicians need a method to assess ... for extensive neuropsychological tests. Penn State College of ... disease (FTD) deficits in judgment and problem-solving in ALS ...
... Computer algorithms might be useful in identifying sources of ... Writing in the International Journal of Environment and ... is to trace such pollution. Groundwater is a ... urban and rural areas. Although groundwater represents a small ...
... -- Heart damage caused by heavy cocaine use can occur ... Researchers assessed the heart health of 30 long-term cocaine users, ... hours after they last used cocaine. They had been using ... 5.5 grams of cocaine per day. Snorting was the ...
... recent study published in Panminerva Medica reveals ... taken by stable heart failure patients as an adjunct ... blood volume ejected with each beat. As a ... and patients become more physically energetic. Furthermore, blood ...
Cached Medicine News:Health News:Three senior Hebrew University faculty members receive Kaye Awards for innovations 2Health News:Brief exam diagnoses cognitive impairment in ALS patients 2Health News:Tracking groundwater pollution to its source 2Health News:Cocaine-Related Heart Damage May Be 'Silent' 2Health News:Study shows pine bark naturally improves heart function 2Health News:Study shows pine bark naturally improves heart function 3Health News:Study shows pine bark naturally improves heart function 4
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
Medicine Products: